Apis Capital Advisors’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-214,000
| Closed | -$4.34M | – | 31 |
|
|
2022
Q4 | $4.34M | Buy |
214,000
+10,000
| +5% | +$203K | 5.03% | 7 |
|
|
2022
Q3 | $2.19M | Buy |
204,000
+8,000
| +4% | +$86K | 3.29% | 10 |
|
|
2022
Q2 | $2.35M | Buy |
196,000
+84,000
| +75% | +$1.01M | 2.65% | 15 |
|
|
2022
Q1 | $2.4M | Buy |
112,000
+2,000
| +2% | +$42.8K | 2.9% | 13 |
|
|
2021
Q4 | $3.7M | Buy |
110,000
+8,000
| +8% | +$269K | 4.1% | 11 |
|
|
2021
Q3 | $2.63M | Buy |
102,000
+18,000
| +21% | +$463K | 2.5% | 18 |
|
|
2021
Q2 | $1.12M | Buy |
84,000
+4,000
| +5% | +$53.5K | 0.97% | 24 |
|
|
2021
Q1 | $850K | Buy |
80,000
+16,000
| +25% | +$170K | 0.77% | 31 |
|
|
2020
Q4 | $514K | Buy |
+64,000
| New | +$514K | 0.5% | 34 |
|
|
2019
Q3 | $256K | Buy |
+17,000
| New | +$256K | 0.4% | 27 |
|